Crossmark

A ferritin-targeted biohybrid triggering ferroptosis immunotherapy via activating endogenous iron and replenishing exogenous iron simultaneously

Published Online: 2025-07-01

Authors

Sheng, Shupei

Zhang, Yan

Jin, Limin

Sun, Weiting

Zhu, Dunwan

Mei, Lin https://orcid.org/0000-0001-6503-5149
Dong, Xia https://orcid.org/0000-0003-3932-8866
Lv, Feng https://orcid.org/0000-0002-0583-1810
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82272154, 32371391)
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 31 May 2024

Accepted: 20 June 2025

First Online: 1 July 2025

Competing interests

: The authors declare no competing interests.

Document is current